TNF and inflammatory bowel disease: In clinical management, controlling intestinal inflammatory activity by employing targeted therapies such as anti-TNF-α and JAK inhibitors, combined with psychological interventions and MDT approaches, is of significant importance for preventing and improving IBD-related ED.